Effectiveness and safety of the schedules of short and long term treatment for tuberculous meningoencephalitis at two hospitals of Lima - Peru
Introduction: To compare the effectiveness and safety of short-term 6 month-treatment and long term 12 month-treatment schedules for meningoencephalitis due to tuberculosis in two hospitals from Lima-Peru. Methods: Comparative, retrospective and observational study. The patients were divided in two...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier España
2011-01-01
|
Series: | Neurología (English Edition) |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2173580811700451 |
id |
doaj-0445d1e2e2e74b83a3fb562165ef593d |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
S. Morales W. Ramos R. Vílchez J. Pérez M. Alvarado |
spellingShingle |
S. Morales W. Ramos R. Vílchez J. Pérez M. Alvarado Effectiveness and safety of the schedules of short and long term treatment for tuberculous meningoencephalitis at two hospitals of Lima - Peru Neurología (English Edition) |
author_facet |
S. Morales W. Ramos R. Vílchez J. Pérez M. Alvarado |
author_sort |
S. Morales |
title |
Effectiveness and safety of the schedules of short and long term treatment for tuberculous meningoencephalitis at two hospitals of Lima - Peru |
title_short |
Effectiveness and safety of the schedules of short and long term treatment for tuberculous meningoencephalitis at two hospitals of Lima - Peru |
title_full |
Effectiveness and safety of the schedules of short and long term treatment for tuberculous meningoencephalitis at two hospitals of Lima - Peru |
title_fullStr |
Effectiveness and safety of the schedules of short and long term treatment for tuberculous meningoencephalitis at two hospitals of Lima - Peru |
title_full_unstemmed |
Effectiveness and safety of the schedules of short and long term treatment for tuberculous meningoencephalitis at two hospitals of Lima - Peru |
title_sort |
effectiveness and safety of the schedules of short and long term treatment for tuberculous meningoencephalitis at two hospitals of lima - peru |
publisher |
Elsevier España |
series |
Neurología (English Edition) |
issn |
2173-5808 |
publishDate |
2011-01-01 |
description |
Introduction: To compare the effectiveness and safety of short-term 6 month-treatment and long term 12 month-treatment schedules for meningoencephalitis due to tuberculosis in two hospitals from Lima-Peru. Methods: Comparative, retrospective and observational study. The patients were divided in two groups: Group 1: long term 12 month-treatment with isoniazid, rifampin, pyrazinamide, and ethambutol for the first 2 months; then isoniazid and rifampin for 10 months. Group 2: short-term 6 month-treatment with isoniazid and rifampin, pyrazinamide and ethambutol for the first 2 months; then isoniazid and rifampin for 4 months. Clinical records, effectiveness, treatment failure, treatment side effects, mortality and late consequences after treatment were reviewed. Results: Twenty-six patients with meningoencephalitis level I were included, 10 received the long term schedule and 16 the short-term schedule treatment. From 51 patients with meningoencephalitis level II, 27 received the long term schedule and 24 the short-term schedule treatment and of 31 patients with meningoencephalitis level III, 18 received the long term schedule treatment and 13 the short-term schedule treatment. There was no statistically significant differences among levels I, II and III when effectiveness of short and long term schedule was evaluated. Moreover, there was no statistically significant difference in the frequency of treatment failure, treatment side effects, mortality and late consequences among groups. Conclusions: Long term 12 month-treatment and short-term 6 month-treatment had similar effectiveness and safety in the treatment of meningoenchephalitis due to tuberculosis in HIV negative patients.bility in work protocols and rationalises the use of the available health care resources. Resumen: Introducción: Comparar la efectividad y seguridad de los esquemas corto de 6 meses y largo de 12 meses en el tratamiento de la meningoencefalitis tuberculosa de pacientes VIH negativos de dos hospitales de Lima-Perú. Métodos: Estudio comparativo, retrospectivo y observacional. Los pacientes recibieron uno de los siguientes esquemas de tratamiento: grupo 1, curso largo de 12 meses de tratamiento con isoniazida, rifampicina, pirazinamida y etambutol los primeros 2 meses; luego isoniazida y rifampicina durante 10 meses. Grupo 2, curso corto de 6 meses con isoniazida, rifampicina, pirazinamida y etambutol los primeros 2 meses; luego isoniazida y rifampicina durante 4 meses. Se revisó las historias clínicas y se evaluó en ambos grupos la efectividad, recaídas, fracaso terapéutico, reacciones adversas a fármacos antituberculosos, mortalidad y secuelas luego de concluir tratamiento. Resultados: Se presentaron 26 pacientes con meningoencefalitis grado I, de los cuales 10 recibieron el esquema de tratamiento largo y 16 el esquema corto; 51 con meningoencefalitis grado II, 27 recibieron el esquema largo y 24 el esquema corto; y 31 con meningoencefalitis grado III, recibiendo 18 el esquema largo y 13 el esquema corto. Al evaluarse la efectividad de los esquemas corto y largo no se encontró diferencia estadísticamente significativa en los grados I, II y III; tampoco existió diferencia estadísticamente significativa en la frecuencia de recaídas, fracaso terapéutico, reacciones adversas a fármacos antituberculosos, en la mortalidad y secuelas. Conclusiones: Los esquemas largo de 12 meses y corto de 6 meses tendrían similar efectividad y seguridad en el tratamiento de la meningoencefalitis tuberculosa de pacientes VIH negativos Keywords: Tuberculous meningoencephalitis, Short and long term treatment, Palabras clave: Meningoencefalitis tuberculosa, Esquemas de tratamiento corto y largo |
url |
http://www.sciencedirect.com/science/article/pii/S2173580811700451 |
work_keys_str_mv |
AT smorales effectivenessandsafetyoftheschedulesofshortandlongtermtreatmentfortuberculousmeningoencephalitisattwohospitalsoflimaperu AT wramos effectivenessandsafetyoftheschedulesofshortandlongtermtreatmentfortuberculousmeningoencephalitisattwohospitalsoflimaperu AT rvilchez effectivenessandsafetyoftheschedulesofshortandlongtermtreatmentfortuberculousmeningoencephalitisattwohospitalsoflimaperu AT jperez effectivenessandsafetyoftheschedulesofshortandlongtermtreatmentfortuberculousmeningoencephalitisattwohospitalsoflimaperu AT malvarado effectivenessandsafetyoftheschedulesofshortandlongtermtreatmentfortuberculousmeningoencephalitisattwohospitalsoflimaperu |
_version_ |
1725188322215591936 |
spelling |
doaj-0445d1e2e2e74b83a3fb562165ef593d2020-11-25T01:06:46ZengElsevier EspañaNeurología (English Edition)2173-58082011-01-01264220226Effectiveness and safety of the schedules of short and long term treatment for tuberculous meningoencephalitis at two hospitals of Lima - PeruS. Morales0W. Ramos1R. Vílchez2J. Pérez3M. Alvarado4Servicio de Neurología y Neurofisiología, Clínica Santa Mónica, Lima, PeruInstituto de Investigaciones Clínicas, Universidad Nacional Mayor de San Marcos, Lima, Peru; Equipo Técnico de Análisis de Situación de Salud, Dirección General de Epidemiología, Ministerio de Salud, Lima, Peru; Corresponding author.Servicio de Medicina Física y Rehabilitación, Hospital EsSalud Alberto Sabogal Sologuren, Callao, PeruInstituto de Investigaciones Clínicas, Universidad Nacional Mayor de San Marcos, Lima, Peru; Servicio de Neurología, Hospital Nacional Dos de Mayo, Lima, PeruPrograma de Control de Tuberculosis, Instituto Nacional de Ciencias Neurológicas Óscar Trelles Montes, Lima, PeruIntroduction: To compare the effectiveness and safety of short-term 6 month-treatment and long term 12 month-treatment schedules for meningoencephalitis due to tuberculosis in two hospitals from Lima-Peru. Methods: Comparative, retrospective and observational study. The patients were divided in two groups: Group 1: long term 12 month-treatment with isoniazid, rifampin, pyrazinamide, and ethambutol for the first 2 months; then isoniazid and rifampin for 10 months. Group 2: short-term 6 month-treatment with isoniazid and rifampin, pyrazinamide and ethambutol for the first 2 months; then isoniazid and rifampin for 4 months. Clinical records, effectiveness, treatment failure, treatment side effects, mortality and late consequences after treatment were reviewed. Results: Twenty-six patients with meningoencephalitis level I were included, 10 received the long term schedule and 16 the short-term schedule treatment. From 51 patients with meningoencephalitis level II, 27 received the long term schedule and 24 the short-term schedule treatment and of 31 patients with meningoencephalitis level III, 18 received the long term schedule treatment and 13 the short-term schedule treatment. There was no statistically significant differences among levels I, II and III when effectiveness of short and long term schedule was evaluated. Moreover, there was no statistically significant difference in the frequency of treatment failure, treatment side effects, mortality and late consequences among groups. Conclusions: Long term 12 month-treatment and short-term 6 month-treatment had similar effectiveness and safety in the treatment of meningoenchephalitis due to tuberculosis in HIV negative patients.bility in work protocols and rationalises the use of the available health care resources. Resumen: Introducción: Comparar la efectividad y seguridad de los esquemas corto de 6 meses y largo de 12 meses en el tratamiento de la meningoencefalitis tuberculosa de pacientes VIH negativos de dos hospitales de Lima-Perú. Métodos: Estudio comparativo, retrospectivo y observacional. Los pacientes recibieron uno de los siguientes esquemas de tratamiento: grupo 1, curso largo de 12 meses de tratamiento con isoniazida, rifampicina, pirazinamida y etambutol los primeros 2 meses; luego isoniazida y rifampicina durante 10 meses. Grupo 2, curso corto de 6 meses con isoniazida, rifampicina, pirazinamida y etambutol los primeros 2 meses; luego isoniazida y rifampicina durante 4 meses. Se revisó las historias clínicas y se evaluó en ambos grupos la efectividad, recaídas, fracaso terapéutico, reacciones adversas a fármacos antituberculosos, mortalidad y secuelas luego de concluir tratamiento. Resultados: Se presentaron 26 pacientes con meningoencefalitis grado I, de los cuales 10 recibieron el esquema de tratamiento largo y 16 el esquema corto; 51 con meningoencefalitis grado II, 27 recibieron el esquema largo y 24 el esquema corto; y 31 con meningoencefalitis grado III, recibiendo 18 el esquema largo y 13 el esquema corto. Al evaluarse la efectividad de los esquemas corto y largo no se encontró diferencia estadísticamente significativa en los grados I, II y III; tampoco existió diferencia estadísticamente significativa en la frecuencia de recaídas, fracaso terapéutico, reacciones adversas a fármacos antituberculosos, en la mortalidad y secuelas. Conclusiones: Los esquemas largo de 12 meses y corto de 6 meses tendrían similar efectividad y seguridad en el tratamiento de la meningoencefalitis tuberculosa de pacientes VIH negativos Keywords: Tuberculous meningoencephalitis, Short and long term treatment, Palabras clave: Meningoencefalitis tuberculosa, Esquemas de tratamiento corto y largohttp://www.sciencedirect.com/science/article/pii/S2173580811700451 |